Elevance Health, Inc. (ELV) Stock Analysis
Healthcare · Healthcare Plans
Sell if holding. Engine safety override at $388.70: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Below-average business quality.
Elevance Health is one of the largest U.S. health insurers with approximately 45.2 million medical members, offering commercial, Medicare and Medicaid health plans primarily under Anthem Blue Cross/Blue Shield brands across 14+ states, plus pharmacy services through CarelonRx.... Read more
Sell if holding. Engine safety override at $388.70: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Below-average business quality. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.0/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 58d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent Developments — Elevance Health, Inc.
Latest news
- Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $435 — benzinga May 20, 2026 positive
- This CH Robinson Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday — benzinga May 20, 2026 positive
- Deutsche Bank Upgrades Elevance Health to Buy, Raises Price Target to $498 — benzinga May 20, 2026 positive
- 10 Health Care Stocks Whale Activity In Today's Session — benzinga May 12, 2026 neutral
- Apple, Amazon, TSMC Top List Of Earnings Triple Plays As Beat-And-Raise Stocks Surge — benzinga May 5, 2026 neutral
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Quality below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $388.70: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Below-average business quality. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $375.01. Score 5.0/10, moderate confidence.
Take-profit target: $393.11 (-0.2% upside). Prior stop was $375.01. Stop-loss: $375.01.
Target reached (-11.2% upside); Quality below floor (3.8 < 4.0).
Elevance Health, Inc. trades at a P/E of 16.7 (forward 13.5). TrendMatrix value score: 6.5/10. Verdict: Sell.
29 analysts cover ELV with a consensus score of 3.8/5. Average price target: $389.
What does Elevance Health, Inc. do?Elevance Health is one of the largest U.S. health insurers with approximately 45.2 million medical members, offering...
Elevance Health is one of the largest U.S. health insurers with approximately 45.2 million medical members, offering commercial, Medicare and Medicaid health plans primarily under Anthem Blue Cross/Blue Shield brands across 14+ states, plus pharmacy services through CarelonRx. Medicaid represents 45.8% of revenue and U.S. government agencies collectively account for approximately 32% of total consolidated revenues.